IGY Life Sciences Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $75K
Latest Deal Amount
  • Investors
  • 1

IGY Life Sciences General Information


Developer of immunoglobulin antibodies designed to tackle global health challenges. The company's antibodies aim to strengthen and supplement the natural immune system against bacterial, viral and autoimmune ailments, enabling humans and animals to live healthy lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 34 Cumberland Street North
  • Suite 201
  • Thunder Bay, Ontario P7A 4L3
  • Canada
+1 (807) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IGY Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Mar-2016 $75K 000.00 Completed Generating Revenue
2. Later Stage VC 01-Mar-2015 0000 000.00 Completed Startup
1. Angel (individual) 17-Feb-2012 $65.1K $65.1K Completed Startup
To view IGY Life Sciences’s complete valuation and funding history, request access »

IGY Life Sciences Executive Team (7)

Name Title Board Seat Contact Info
Terry Dyck Founding Member, Chief Executive Officer, President & Board Member
Cary Wasser Chief Financial Officer
Jeff Stubbings Chief Operating Officer
Huan Nguyen Ph.D Chief Scientific Officer
Jit Mistry Director of Marketing
You’re viewing 5 of 7 executive team members. Get the full list »

IGY Life Sciences Board Members (4)

Name Representing Role Since
Brian Andersen Self Board Member 000 0000
David Fyhrie IGY Life Sciences Board Member 000 0000
Terry Dyck IGY Life Sciences Founding Member, Chief Executive Officer, President & Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »

IGY Life Sciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IGY Life Sciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Legacy Partners Wealth Strategies Other Minority 000 0000 000000 0
To view IGY Life Sciences’s complete investors history, request access »